Fulcrum Debuts SP1/Carbon Nanotube Reinforcement Solution for PAN/Phenolic Composites

Fulcrum SP Materials Ltd, a world leader in innovative nano-technology for enhanced composite materials, today introduced its SP1/CNT reinforcement solution for PAN/phenolic composites. Fulcrum has demonstrated that flat-wise tensile strength more than doubles, and inter-laminar shear strength increases significantly, while preserving overall composite strength. These improvements were achieved using small amounts of Fulcrum's proprietary SP1/CNT complex (0.2%-0.3% by weight of the PAN fabric).

This breakthrough technology in phenolic resins creates opportunities for customers to implement superior nano-reinforced phenolic-based composites and to introduce PAN/Phenolic-based composites for multiple new uses and applications, such as thermal aerospace applications.

"Our customers can now introduce PAN/phenolic composites to demanding aerospace applications and by using Fulcrum's proprietary SP1/CNT technology, can achieve greater performance of their composite parts at an affordable cost. This segment of our business is growing constantly and we will be expanding our offering of such solutions in the near future", said Nimrod Litvak, Fulcrum's CEO.

Fulcrum will be presenting at the JEC Europe 2014 during 11-13 March, at booth Q77 in Pavilion 7.2.

About Fulcrum SP Materials Ltd:

Established in 2007, Fulcrum SP Materials is a nanotechnology company commercializing the use of nanoparticles in the rapidly growing $106 billion composites market (Source: JEC Composites). The composites market includes raw materials such as carbon/glass fiber and aramid, and is commonly used in industries such as aerospace, construction, transport and marine, wind energy and sports equipment. Fulcrum's proprietary SP1/CNT technology can significantly improve the performance properties of composites; enabling cost-effective manufacture of stronger and lighter parts. From its headquarters and pilot plant in Israel, Fulcrum is working in close cooperation with a number of leading multinational companies to develop a range of innovative new commercial products for various end-markets.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.